Interactive Investor
>>

PharmaCyte Biotech Inc (NASDAQ:PMCB) Share Price

PMCB

PharmaCyte Biotech Inc

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer.PharmaCyte Biotech Inc is clinical stage biotechnology company. It is engaged in developing and preparing commercialize treatments for cancer and diabetes based on proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®.

NASDAQ:PMCB

US71715X2036

USD

Loading...

Loading Comparison

Latest PMCB News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News